Guardant Health and Trial Library announced a strategic collaboration to increase access to cancer clinical trials in the United States. The collaboration combines Guardant Health's suite of cutting-edge precision oncology diagnostics with Trial Library's AI-powered matching and patient navigation platform. Together, the companies aim to streamline the identification, referral, and enrollment of patients into precision oncology clinical trials, helping providers offer new treatment opportunities to a broader and more representative patient population.
Guardant's comprehensive real-world data capabilities, powered by a growing platform of more than 1 million patients tested, will help identify relevant patients for clinical trials based on biomarker and clinical data. Trial Library's platform unlocks access to clinical trials in community-based clinical settings across more than 320 clinics and 1,500 providers nationwide through AI-enabled provider activation, compliant eligible patient identification and longitudinal navigation throughout the trial lifecycle.
